d.restrepo
Submits third-party assay reports on material purchased directly. Based in Verona.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.16%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042436 | Ipamorelin | Homopeptide | HOMO-2608-A3930 | Janoshik | 2026-Q3 | 99.70 | 5.28 | 99.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020955 | Semaglutide | WXT | WXT-2505-P3150 | Janoshik | 2025-Q4 | 99.17 | 5.08 | 95.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020313 | CJC-1295 (no DAC) | GGPeps | GGPE-2408-G2525 | Janoshik | 2025-Q1 | 99.12 | 2.90 | 95.6 | Supplier-supplied | 0 | PASS |
| AX-2025-018417 | BPC-157 | WWB | WWB-2408-T2155 | Janoshik | 2025-Q1 | 99.39 | 4.93 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004595 | Enclomiphene citrate | TFC | TFC-2404-J9626 | Janoshik | 2024-Q3 | 99.16 | 3.82 | 105.7 | Buyer-sourced | 0 | FAIL |
| AX-2024-005268 | VIP | BCH | BCH-2405-R4888 | Kestrel | 2024-Q3 | 97.70 | 4.42 | 106.9 | Buyer-sourced | 0 | PASS |